Key Dates

Related Announcements

NOT-OD-22-166 - Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People

Issued by

National Cancer Institute (NCI)

September 15, 2022

Purpose

The purpose of this Notice is to inform the extramural community that, effective immediately, NCI will participate in NOT-OD-22-166, "Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People".

NOT-OD-22-166 has been updated in the following ways to reflect NCI’s participation in this NOSI (in bold italics):

Issued by:

National Cancer Institute (NCI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Minority Health and Health Disparities (NIMHD)

National Center for Complementary and Integrative Health (NCCIH)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

Sexual and Gender Minority Research Office (SGMRO)

Purpose, IC-Specific Application and Submission Information

NCI-specific information to reflect NCI's participation in this funding opportunity announcement.

This paragraph is to be added after NINDS’ Research Interests and before the section entitled Eligible FOAs

NCI encourages research to identify the unique needs of bi/bi+ populations across the cancer control continuum, including prevention, early detection, diagnosis, treatment, survivorship, and end of life care. Areas of programmatic interest include but are not limited to:

• Evaluating methods for effectively identifying, recruiting, and retaining bi/bi+ individuals in all types of research studies;
• Examining the relative risk of cancer risk factors (e.g., smoking, tobacco use, alcohol consumption, poor diet quality, sedentary behavior, obesity, aging, nulliparity, and infections such as HPV or HIV) and underlying mechanisms of risk (social, behavioral, biological, clinical, and developmental) in bi/bi+ populations in comparison to monosexual individuals;
• Assessing differential cancer risk by cancer site to inform risk reduction interventions, screening, or other decision-making options for early cancer detection;
• Assessing the impact of stigma, discrimination, victimization, behavioral health, and other risk factors on utilization of cancer preventive, screening, and care services;
• Investigating cancer care needs, delivery, utilization, quality of care, and patient health outcomes including quality of life and well-being among bi/bi+ populations;
• Investigating barriers to cancer healthcare information and treatment, including lack of access to and utilization of cancer healthcare services, that may lead bi/bi+ populations to avoid or delay seeking health care;
• Examining provider understanding of and communication with bi/bi+ patients and cancer survivors including intervention development to improve the quality of health information shared with bi/bi+ patients and survivors, and interventions to improve shared decision-making;
• Examining the intersection of contextual factors (e.g., race, geography, socioeconomic status, and social determinants of health) on cancer health outcomes;
• Investigating positive and/or protective factors (e.g., family and/or social support) in cancer prevention, treatment, and survivorship;
• Exploring the effects of policy and legislative efforts that restrict sexual and gender minority health care in general on the health and well-being of bi/bi+ populations specifically;
• Developing effective interventions across the cancer control continuum, through the adaptation of existing interventions or creation of novel interventions specific to bi/bi+ populations, targeting individual, family, community, provider, health system, and policy levels, to improve cancer health outcomes.

Finally, the following section has been modified by the addition of NCI Scientific/Research Contact(s) and Financial/Grants Management Contact(s) to the existing list.

Inquiries

Please direct all inquiries to the contacts in Section VII of the listed funding opportunity announcements with the following additions/substitutions:

Scientific/Research Contact(s)

Christopher Barnhart, PhD
Sexual & Gender Minority Research Office (SGMRO)
Telephone: 301-594-8983
Email: christopher.barnhart@nih.gov

Melissa Treviño, PhD
National Center for Complementary & Integrative Health (NCCIH)
Telephone: 301-768-7115
Email: melissa.trevino@nih.gov

Melissa S Gerald, PhD
National Institute on Aging (NIA)
Telephone: 301-451-4503
Email: geraldmel@mail.nih.gov

Robert Freeman, PhD
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-8820
Email: rfreeman@mail.nih.gov

Keith W Crawford, RPh, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2816
Email: keith.crawford@nih.gov

Ronna Popkin, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-5121
Email: ronna.popkin@nih.gov

Carol B Hubner, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-5926
Email: chubner@nida.nih.gov

Dena Fischer, DDS, MSD, MS
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-4876
Email: dena.fischer@nih.gov

Susannah Allison, PhD
Scientific Contact for HIV-related inquiries
National Institute of Mental Health (NIMH)
Telephone: 240-627-3861
Email: allisonsu@mail.nih.gov

Tamara Lewis Johnson, MPH, MBA
Scientific Contact for non-HIV-related inquiries
National Institute of Mental Health (NIMH)
Telephone: 301-594-7963
Email: tamara.lewisjohnson@nih.gov

Crystal Barksdale, PhD, MPH
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-827-4228
Email: crystal.barksdale@nih.gov

Erica L Littlejohn, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-435-2719
Email: Erica.Littlejohn@nih.gov

Jennifer Alvidrez, PhD
Office of Disease Prevention (ODP)
Telephone: 301-827-0071
Email: Jennifer.alvidrez@nih.gov

David Dean Jr, PhD, MS
National Cancer Institute (NCI)
Telephone: 240-276-7803
Email: chipper.dean@nih.gov

Financial/Grants Management Contact(s)

Debbie Chen
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-594-3788
Email: debbie.chen@nih.gov

Ryan Blakeney
National Institute on Aging (NIA)
Telephone: 301-451-9802
Email: blakeneyr@mail.nih.gov

Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email: jfox@mail.nih.gov

Sam Ashe
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-435-4799
Email: Samuel.Ashe@nih.gov

Margaret Young
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-642-4552
Email: margaret.young@nih.gov

Pamela G Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-1159
Email: pfleming@nida.nih.gov

Diana Rutberg, MBA
National Institute of Dental & Craniofacial Research (NIDCR)
Telephone: 301-594-4798
Email: dr258t@nih.gov

Rita Sisco
National Institute of Mental Health (NIMH)
Telephone: 301-443-2805
Email: siscor@mail.nih.gov

Priscilla Grant, JD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8412
Email: pg38h@nih.gov

Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Email: ChiefGrantsManagementOfficer@ninds.nih.gov

Modified to read (by addition in bold italics):

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: wolfreyc@mail.nih.gov

All other aspects of NOT-OD-22-166 remain unchanged.

Inquiries

Please direct all inquiries to:

David Dean Jr, PhD, MS
National Cancer Institute (NCI)
Telephone: 240-276-7803
Email: chipper.dean@nih.gov